The Use of Monoclonal Antibodies and Immune Markers in the Diagnosis, Prognosis, and Therapy of Acute Leukemia
- 31 January 1994
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 8 (1) , 59-75
- https://doi.org/10.1016/s0887-7963(94)70098-5
Abstract
No abstract availableThis publication has 104 references indexed in Scilit:
- A classification of acute leukaemia for the 1990sAnnals of Hematology, 1991
- Routine immunophenotyping of acute leukemias (Reply)Annals of Hematology, 1990
- Generation and maintenance of hybridomasImmunology Today, 1987
- Bone marrow purgingImmunology Today, 1987
- Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1987
- Clinical Importance of Myeloid Antigen Expression in Adult Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1987
- New Promise for Autologous Marrow Transplants in LeukemiaNew England Journal of Medicine, 1986
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Immunologically Defined Subclasses of Acute Lymphoblastic Leukaemia in Children: their Relationship to Presentation Features and PrognosisBritish Journal of Haematology, 1981